Abstract: Disclosed herein is an autologous composition comprising mesenchymal stem stromal cells, wherein the mesenchymal stem stromal cells are derived from adipose tissue collected by punch biopsy from a subject, and the use for the treatment of a disease, including a disease with arthritic lesion progression.
Type:
Application
Filed:
May 17, 2023
Publication date:
September 3, 2026
Applicants:
Theracell Laboratories, Orgenesis Inc.
Inventors:
FOTIOS SAKELLARIDIS, POLYCHRONIS FATOUROS, MARIA KONTOU